Literature DB >> 1277578

Cell-mediated immunity to gluten fraction III in adult coeliac disease.

G K Holmes, P Asquith, W T Cooke.   

Abstract

Peripheral blood lymphocytes were obtained from twenty-seven healthy control subjects, twenty-one coeliac patients on a gluten-free diet and fourteen patients on a normal diet. When the cells were cultured in vitro in the presence of 2 and 4 mg of gluten fraction III, there were significant increases in the mean ratios of response for lymphocytes from gluten-free coeliacs compared to healthy controls after 4, 5 and 6 days of culture, but for those on a normal diet significant increases were found only when using 4 mg of gluten on the 4th and 5th days of culture. When three further patients were changed from a normal to a gluten-free diet, the ratios of response for their lymphocytes increased. The results suggest that certain coeliacs may exhibit a weak delayed hypersensitivity reaction to gluten. Its more ready demonstration in patients on a gluten-free diet could be explained on the release of sensitized lymphocytes from the intestinal mucosa into the peripheral circulation after gluten withdrawal.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1277578      PMCID: PMC1538424     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Immunoglobulins in the skin in dermatitis herpetiformis and coeliac disease.

Authors:  P P Seah; L Fry; J S Stewart; B L Chapman; A V Hoffbrand; E J Holborow
Journal:  Lancet       Date:  1972-03-18       Impact factor: 79.321

2.  Anti-reticulin antibodies in childhood coeliac disease.

Authors:  P P Seah; L Fry; M A Rossiter; A V Hoffbrand; E J Holborow
Journal:  Lancet       Date:  1971-09-25       Impact factor: 79.321

3.  Unique antibody to basement membrane in patients with selective IgA deficiency and coeliac disease.

Authors:  A J Ammann; R Hong
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

4.  Intestinal antibodies to wheat fractions in celiac disease.

Authors:  J Katz; F S Kantor; T Herskovic
Journal:  Ann Intern Med       Date:  1968-12       Impact factor: 25.391

5.  Cellular infiltrate of jejunal biopsies in adult coeliac disease in relation to gluten withdrawal.

Authors:  G K Holmes; P Asquith; P L Stokes; W T Cooke
Journal:  Gut       Date:  1974-04       Impact factor: 23.059

6.  Relationship of in vitro lymphocyte transformation to delayed hypersensitivity in guinea pigs and man.

Authors:  J J Oppenheim
Journal:  Fed Proc       Date:  1968 Jan-Feb

7.  Lymphoreticular dysfunction in idiopathic steatorrhoea.

Authors:  C F McCarthy; I D Fraser; K T Evans; A E Read
Journal:  Gut       Date:  1966-04       Impact factor: 23.059

8.  Immunochemical studies on the serum, intestinal secretions and intestinal mucosa in patients with adult celiac disease and other forms of the celiac syndrome.

Authors:  A P Douglas; P A Crabbé; J R Hobbs
Journal:  Gastroenterology       Date:  1970-09       Impact factor: 22.682

9.  Precipitins to dietary proteins in serum and upper intestinal secretions of coeliac children.

Authors:  A Ferguson; F Carswell
Journal:  Br Med J       Date:  1972-01-08

10.  Digestion of gluten peptides by normal human jejunal mucosa and by mucosa from patients with adult coeliac disease.

Authors:  A P Douglas; C C Booth
Journal:  Clin Sci       Date:  1970-01       Impact factor: 6.124

View more
  8 in total

1.  DNA-synthesizing cells in the blood in coeliac disease and inflammatory bowel disease.

Authors:  G K Holmes; P M Bratt; N R Ling; W T Cooke
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

2.  The distribution of gluten-sensitive lymphocytes in coeliac patients--is it related to dietary gluten?

Authors:  P D Howdle; F G Simpson; M S Losowsky
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

3.  Ultrastructural analysis of plasma cells in coeliac patients.

Authors:  M Guix; J M Skinner; R Whitehead
Journal:  Gut       Date:  1979-06       Impact factor: 23.059

4.  Cell-mediated immunity to gluten fraction III in adult coeliac disease.

Authors:  A W Bullen; M S Losowsky
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

5.  Cellular response to alpha-gliadin in untreated coeliac disease.

Authors:  C O'Farrelly; C Feighery; J F Greally; D G Weir
Journal:  Gut       Date:  1982-01       Impact factor: 23.059

6.  T cell proliferation, MHC class II restriction and cytokine products of gliadin-stimulated peripheral blood mononuclear cells (PBMC).

Authors:  J O'Keeffe; K Mills; J Jackson; C Feighery
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

7.  Cellular hypersensitivity to a synthetic dodecapeptide derived from human adenovirus 12 which resembles a sequence of A-gliadin in patients with coeliac disease.

Authors:  G J Mantzaris; J A Karagiannis; J D Priddle; D P Jewell
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

8.  Impaired suppressor activity in children affected by coeliac disease.

Authors:  C Pignata; R Troncone; G Monaco; M Ciriaco; E Farris; G Carminati; S Auricchio
Journal:  Gut       Date:  1985-03       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.